neomycin sulfate - Profile

What are the generic sources for neomycin sulfate and what is the scope of freedom to operate?

Neomycin sulfate is the generic ingredient in thirteen branded drugs marketed by Pharmacia And Upjohn, X Gen Pharms, Pfizer, Bristol Myers Squibb, Chartwell Molecular, Lannett, Lilly, Pharmobedient, Roxane, Sandoz, Solaris Pharma Corp, Teva, Glaxosmithkline, Alcon, Watson Labs, Xgen Pharms, Monarch Pharms, Allergan, Merck, Savage Labs, Fougera, and Pharmaderm, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

Summary for neomycin sulfate

US Patents:	0
Tradenames:	13
Applicants:	22
NDAs:	31

US Patents and Regulatory Information for neomycin sulfate

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmacia And Upjohn	MYCIFRADIN	neomycin sulfate	SOLUTION;ORAL	050285-001	Approved Prior to Jan 1, 1982		DISCN	No	No
X Gen Pharms	NEO-FRADIN	neomycin sulfate	SOLUTION;ORAL	065010-001	May 23, 2002		DISCN	No	No
Pharmacia And Upjohn	MYCIFRADIN	neomycin sulfate	TABLET;ORAL	060520-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Pfizer	NEOBIOTIC	neomycin sulfate	TABLET;ORAL	060475-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Bristol Myers Squibb	NEOMYCIN SULFATE	neomycin sulfate	TABLET;ORAL	060365-001	Approved Prior to Jan 1, 1982		DISCN	No	No